What the Future Holds for Informed Consent

June 30, 2016
Mika Lindroos, Director of Product Management at CRF Health, discusses the advantages of electronic informed consent in clinical trials and how by integrating this process with eCOA technologies, researchers can reduce burden for study teams, decrease regulatory risk, increase participant comprehension, and improve overall study outcomes. Courtesy of PharmaFocus (original link: http://edition.pagesuite-professional.co.uk/launch.aspx?eid=b3114258-2357-4dee-b791-295cd1220624&pnum=18)
Previous
The Value of Electronic Informed Consent
The Value of Electronic Informed Consent

Next
Innovations in e-Consent: Reducing Regulatory Risk While Improving Participant Comprehension
Innovations in e-Consent: Reducing Regulatory Risk While Improving Participant Comprehension

As regulatory agencies push for more effective informed consent processes in clinical trials, eConsent can ...